Annual CFO
$293.80 M
+$135.00 M+85.01%
December 31, 2023
Summary
- As of February 7, 2025, SGRY annual cash flow from operations is $293.80 million, with the most recent change of +$135.00 million (+85.01%) on December 31, 2023.
- During the last 3 years, SGRY annual CFO has risen by +$46.90 million (+19.00%).
- SGRY annual CFO is now at all-time high.
Performance
SGRY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$65.20 M
-$17.60 M-21.26%
September 30, 2024
Summary
- As of February 7, 2025, SGRY quarterly cash flow from operations is $65.20 million, with the most recent change of -$17.60 million (-21.26%) on September 30, 2024.
- Over the past year, SGRY quarterly CFO has dropped by -$17.60 million (-21.26%).
- SGRY quarterly CFO is now -64.16% below its all-time high of $181.90 million, reached on June 30, 2020.
Performance
SGRY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$251.30 M
-$39.40 M-13.55%
September 30, 2024
Summary
- As of February 7, 2025, SGRY TTM cash flow from operations is $251.30 million, with the most recent change of -$39.40 million (-13.55%) on September 30, 2024.
- Over the past year, SGRY TTM CFO has dropped by -$39.40 million (-13.55%).
- SGRY TTM CFO is now -14.47% below its all-time high of $293.80 million, reached on December 31, 2023.
Performance
SGRY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SGRY Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +85.0% | -21.3% | -13.6% |
3 y3 years | +19.0% | +231.0% | +188.5% |
5 y5 years | +103.2% | +231.0% | +188.5% |
SGRY Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +237.3% | -37.7% | +805.6% | -14.5% | +188.5% |
5 y | 5-year | at high | +237.3% | -64.2% | +2734.8% | -14.5% | +229.4% |
alltime | all time | at high | +1238.6% | -64.2% | +2734.8% | -14.5% | +2541.4% |
Surgery Partners Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $65.20 M(-21.3%) | $251.30 M(-13.6%) |
Jun 2024 | - | $82.80 M(+103.4%) | $290.70 M(+11.8%) |
Mar 2024 | - | $40.70 M(-35.0%) | $260.00 M(-11.5%) |
Dec 2023 | $293.80 M(+85.0%) | $62.60 M(-40.2%) | $293.80 M(+23.2%) |
Sep 2023 | - | $104.60 M(+100.8%) | $238.40 M(+45.8%) |
Jun 2023 | - | $52.10 M(-30.1%) | $163.50 M(+6.5%) |
Mar 2023 | - | $74.50 M(+934.7%) | $153.50 M(-3.3%) |
Dec 2022 | $158.80 M(+82.3%) | $7.20 M(-75.8%) | $158.80 M(-7.3%) |
Sep 2022 | - | $29.70 M(-29.5%) | $171.30 M(+9.5%) |
Jun 2022 | - | $42.10 M(-47.2%) | $156.50 M(+34.1%) |
Mar 2022 | - | $79.80 M(+305.1%) | $116.70 M(+34.0%) |
Dec 2021 | $87.10 M(-64.7%) | $19.70 M(+32.2%) | $87.10 M(+14.2%) |
Sep 2021 | - | $14.90 M(+547.8%) | $76.30 M(-13.6%) |
Jun 2021 | - | $2.30 M(-95.4%) | $88.30 M(-67.0%) |
Mar 2021 | - | $50.20 M(+464.0%) | $267.90 M(+8.5%) |
Dec 2020 | $246.90 M(+90.7%) | $8.90 M(-66.9%) | $246.90 M(-6.3%) |
Sep 2020 | - | $26.90 M(-85.2%) | $263.40 M(-10.2%) |
Jun 2020 | - | $181.90 M(+522.9%) | $293.40 M(+112.3%) |
Mar 2020 | - | $29.20 M(+15.0%) | $138.20 M(+6.7%) |
Dec 2019 | $129.50 M | $25.40 M(-55.4%) | $129.50 M(-13.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | $56.90 M(+113.1%) | $149.60 M(+22.4%) |
Jun 2019 | - | $26.70 M(+30.2%) | $122.20 M(-9.5%) |
Mar 2019 | - | $20.50 M(-54.9%) | $135.10 M(-6.6%) |
Dec 2018 | $144.60 M(+15.5%) | $45.50 M(+54.2%) | $144.60 M(+45.9%) |
Sep 2018 | - | $29.50 M(-25.5%) | $99.10 M(+42.4%) |
Jun 2018 | - | $39.60 M(+32.0%) | $69.60 M(+34.9%) |
Mar 2018 | - | $30.00 M(+38.9%) | $51.60 M(-52.1%) |
Jun 2017 | - | $21.60 M(-38.1%) | $107.67 M(-20.2%) |
Mar 2017 | - | $34.87 M(+7.7%) | $134.87 M(+7.7%) |
Dec 2016 | $125.24 M(+48.2%) | $32.38 M(+72.0%) | $125.24 M(+7.0%) |
Sep 2016 | - | $18.83 M(-61.4%) | $117.05 M(-8.2%) |
Jun 2016 | - | $48.79 M(+93.3%) | $127.53 M(+27.3%) |
Mar 2016 | - | $25.24 M(+4.4%) | $100.21 M(+18.6%) |
Dec 2015 | $84.48 M(+284.9%) | $24.19 M(-17.5%) | $84.48 M(+40.1%) |
Sep 2015 | - | $29.31 M(+36.5%) | $60.29 M(+94.6%) |
Jun 2015 | - | $21.47 M(+125.7%) | $30.99 M(+225.7%) |
Mar 2015 | - | $9.51 M | $9.51 M |
Dec 2014 | $21.95 M(-55.3%) | - | - |
Dec 2013 | $49.08 M(+5.8%) | - | - |
Dec 2012 | $46.38 M | - | - |
FAQ
- What is Surgery Partners annual cash flow from operations?
- What is the all time high annual CFO for Surgery Partners?
- What is Surgery Partners annual CFO year-on-year change?
- What is Surgery Partners quarterly cash flow from operations?
- What is the all time high quarterly CFO for Surgery Partners?
- What is Surgery Partners quarterly CFO year-on-year change?
- What is Surgery Partners TTM cash flow from operations?
- What is the all time high TTM CFO for Surgery Partners?
- What is Surgery Partners TTM CFO year-on-year change?
What is Surgery Partners annual cash flow from operations?
The current annual CFO of SGRY is $293.80 M
What is the all time high annual CFO for Surgery Partners?
Surgery Partners all-time high annual cash flow from operations is $293.80 M
What is Surgery Partners annual CFO year-on-year change?
Over the past year, SGRY annual cash flow from operations has changed by +$135.00 M (+85.01%)
What is Surgery Partners quarterly cash flow from operations?
The current quarterly CFO of SGRY is $65.20 M
What is the all time high quarterly CFO for Surgery Partners?
Surgery Partners all-time high quarterly cash flow from operations is $181.90 M
What is Surgery Partners quarterly CFO year-on-year change?
Over the past year, SGRY quarterly cash flow from operations has changed by -$17.60 M (-21.26%)
What is Surgery Partners TTM cash flow from operations?
The current TTM CFO of SGRY is $251.30 M
What is the all time high TTM CFO for Surgery Partners?
Surgery Partners all-time high TTM cash flow from operations is $293.80 M
What is Surgery Partners TTM CFO year-on-year change?
Over the past year, SGRY TTM cash flow from operations has changed by -$39.40 M (-13.55%)